Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease. (Q54345809)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease. |
scientific article |
Statements
Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease. (English)
Azuma E
Yamamoto H
Kaplan J
1 September 1989
143
5
1524-1529